May 29, 2003

Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovorin: Interim Results of a Phase III Trial

Key Points

Key points are not available for this paper at this time.

Abstract

For patients with metastatic colorectal cancer, second-line treatment with FOLFOX4 is superior to treatment with LVFU2 in terms of RR, TTP, and relief of TRS.

Bookmark

Cite This Study

Rothenberg et al. (Thu,) studied this question.

synapsesocial.com/papers/69d7cd4e319e71454dbedab9 https://doi.org/https://doi.org/10.1200/jco.2003.11.126

Bookmark